Apr 16, 2026 8:37 am EDT Profound Medical to Release First Quarter 2026 Financial Results on May 7 – Conference Call to Follow
Apr 14, 2026 7:30 am EDT Profound Medical to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Apr 1, 2026 8:15 am EDT Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
Mar 27, 2026 7:45 am EDT Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure™ Milestone
Mar 13, 2026 10:30 am EDT CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA Procedure™ to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence
Mar 9, 2026 8:30 am EDT Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24
Feb 12, 2026 4:30 pm EST Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
Feb 12, 2026 8:30 am EST Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease
Feb 5, 2026 8:00 am EST PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health